Abstract
Bronchiectasis is a pathological abnormality of the airways in which there is permanent dilatation and thickening of the airways. Precise incidence/prevalence in India is not known. Recent data suggests that about 1 % young children admitted in a hospital with pneumonia may develop bronchiectasis. Due to significant burden of pneumonia in young children in developing countries including India, it may be a significant problem that is possibly under recognized. Causes of bronchiectasis depend on the burden of respiratory infections and availability of the investigations for identification of the underlying cause. Post infectious causes are common in countries where infections are more common; however, since these countries are usually resource constrained and therefore, are not able to appropriately diagnose the other causes, leading to more than real overrepresentation of infections as a cause. In countries with less of infectious illnesses and good diagnostic facilities, malformations of airways, immune deficiency disorders and primary ciliary dyskinesia are common causes of bronchiectasis. High resolution CT scan of chest confirms the diagnosis. Treatment is supportive care and consists of maintenance of nutrition, airway clearance and antibiotics for exacerbations. Medical treatment is successful in the majority.
Similar content being viewed by others
References
Roberts HJ, Hubbard R. Trends in bronchiectasis mortality in England and Wales. Respir Med. 2010;104:e981–5.
Metcalfe TR, Edwards E, Byrnes C. New Zealand national incidence of bronchiectasis “too high” for a developed country. Arch Dis Child. 2005;90:737–40.
Chang AB, Bell SC, Torzillo PJ, et al; Extended Voting Group. Chronic suppurative lung disease and bronchiectasis in children and adults in Australia and New Zealand Thoracic Society of Australia and New Zealand guidelines. Med J Aust. 2015;202:130.
Edmond K, Scott S, Korczak V, et al. Long term sequelae from childhood pneumonia; systematic review and meta-analysis. PLoS One. 2012;7:e31239.
Rudan I, O'Brien KL, Nair H, et al; Child Health Epidemiology Reference Group (CHERG). epidemiology and etiology of childhood pneumonia in 2010: estimates of incidence, severe morbidity, mortality, underlying risk factors and causative pathogens for 192 countries. J Glob Health. 2013;3:010401.
Angrill J, Agusti C, De Celis R, et al. Bronchial inflammation and colonization in patients with clinically stable bronchiectasis. Am J Respir Crit Care Med. 2001;164:1628–32.
Loukides S, Bouros D, Papatheodorou G, Lachanis S, Panagou P, Siafakas NM. Exhaled H(2)O(2) in steady-state bronchiectasis: relationship with cellular composition in induced sputum, spirometry, and extent and severity of disease. Chest. 2002;121:81–7.
Watt AP, Brown V, Courtney J, et al. Neutrophil apoptosis, proinflammatory mediators and cell counts in bronchiectasis. Thorax. 2004;59:231–6.
Verhagen LM, de Groot R. Recurrent, protracted and persistent lower respiratory tract infection: a neglected clinical entity. J Infect. 2015;71:S106–11.
Li AM, Sonnappa S, Lex C, et al. Non-CF bronchiectasis: does knowing the aetiology lead to changes in management? Eur Respir J. 2005;26:8–14.
Karakoc GB, Yilmaz M, Altintas DU, Kendirli SG. Bronchiectasis: still a problem. Pediatr Pulmonol. 2001;32:175–8.
Eastham KM, Fall AJ, Mitchell L, Spencer DA. Paediatric lung disease: the need to redefine non-cystic fibrosis bronchiectasis in childhood. Thorax. 2004;59:324–7.
Nikolaizik WH, Warner JO. Aetiology of chronic suppurative lung disease. Arch Dis Child. 1994;70:141–2.
Karadag B, Karakoc F, Ersu R, Kut A, Bakac S, Dagli E. Non-cystic fibrosis bronchiectasis in children: a persisting problem in developing countries. Respiration. 2005;72:233–8.
Kumar A, Lodha R, Kumar P, Kabra SK. Non-cystic fibrosis bronchiectasis in children: clinical profile, etiology and outcome. Indian Pediatr. 2015;52:35–7.
Hill AT, Pasteur M, Cornford C, Welham S, Bilton D. Primary care summary of the British thoracic society guideline on the management of non-cystic fibrosis bronchiectasis. Prim Care Respir J. 2011;20:135–40.
Swensen SJ, Aughenbaugh GL, Brown LR. High-resolution computed tomography of the lung. Mayo Clin Proc. 1989;64:1284–94.
Kuhn JP, Brody AS. High-resolution CT of pediatric lung disease. Radiol Clin N Am. 2002;40:89–110.
Barker AF. Medical progress: bronchiectasis. N Engl J Med. 2002;346:1383–93.
Kang EY, Miller RR, Muller NL. Bronchiectasis: comparison of preoperative thin-section CT and pathologic findings in resected specimens. Radiology. 1995;195:649–54.
Mansour Y, Beck R, Danino J, Bentur L. Resolution of severe bronchiectasis after removal of long-standing retained foreign body. Pediatr Pulmonol. 1998;25:130–2.
Karakoç F, Karadağ B, Akbenlioğlu C, et al. Foreign body aspiration: what is the outcome? Pediatr Pulmonol. 2002;34:30–6.
Gaillard EA, Carty H, Heaf D, Smyth RL. Reversible bronchial dilatation in children: comparison of serial high-resolution computer tomography scans of the lungs. Eur J Radiol. 2003;47:215–20.
Spencer DA. From hemp seed and porcupine quill to HRCT: advances in the diagnosis and epidemiology of bronchiectasis. Arch Dis Child. 2005;90:712–4.
Montella S, Maglione M, Bruzzese D, et al. Magnetic resonance imaging is an accurate and reliable method to evaluate non-cystic fibrosis paediatric lung disease. Respirology. 2012;17:87–91.
Kabra SK, Lodha R, Ramesh P, Sarthi M. Fiberoptic bronchoscopy in children an audit from a tertiary care center. Indian Pediatr. 2008;45:917–9.
Kabra SK, Kabra M, Lodha R, Shastri S. Cystic fibrosis in India. Pediatr Pulmonol. 2007;42:1087–94.
Popatia R, Haver K, Casey A. Primary ciliary dyskinesia: an update on new diagnostic modalities and review of the literature. Pediatr Allergy Immunol Pulmonol. 2014;27:51–9.
Werner C, Onnebrink JG, Omran H. Diagnosis and management of primary ciliary dyskinesia. Cilia. 2015;4:2.
Agarwal R, Chakrabarti A, Shah A, et al; ABPA complicating asthma ISHAM working group. Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria. Clin Exp Allergy. 2013;43:850–73.
Welsh EJ, Evans DJ, Fowler SJ, Spencer S. Interventions for bronchiectasis: an overview of Cochrane systematic reviews. Cochrane Database Syst Rev. 2015;7:CD010337. [Epub ahead of print]
Snijders D, Fernandez Dominguez B, Calgaro S, et al. Mucociliary clearance techniques for treating non-cystic fibrosis bronchiectasis: is there evidence? Int J Immunopathol Pharmacol. 2015;28:150–9.
Bothra M, Lodha R, Kabra SK. Tobramycin for the treatment of bacterial pneumonia in children. Expert Opin Pharmacother. 2012;13:565–71.
Kuruvilla M, de la Morena MT. Antibiotic prophylaxis in primary immune deficiency disorders. J Allergy Clin Immunol Pract. 2013;1:573–82.
Serisier DJ, Martin ML. Long-term, low-dose erythromycin in bronchiectasis subjects with frequent infective exacerbations. Respir Med. 2011;105:946–9.
Anwar GA, Bourke SC, Afolabi G, Middleton P, Ward C, Rutherford RM. Effects of long-term low-dose azithromycin in patients with non-CF bronchiectasis. Respir Med. 2008;102:1494–6.
Contributions
AKG: Involved in literature search, manuscript writing; RL: Involved in manuscript writing; SKK: Involved in literature search, manuscript writing and will act as guarantor for manuscript.
Conflict of Interest
None.
Source of Funding
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gupta, A.K., Lodha, R. & Kabra, S.K. Non Cystic Fibrosis Bronchiectasis. Indian J Pediatr 82, 938–944 (2015). https://doi.org/10.1007/s12098-015-1866-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12098-015-1866-4